In this issue:
PERC and thromboembolic events in the ED
Aspirin vs. rivaroxaban for preventing VTE after hip/knee arthroplasty
Edoxaban for cancer-associated VTE
Infection increases VTE risk
ICH and in-hospital mortality for DOACs vs. other oral anticoagulants
Sotatercept for anaemia in low-risk myelodysplastic syndrome
Eltrombopag for severe aplastic anaemia
Nilotinib vs. imatinib in Japanese patients with new chronic-phase CML
Selinexor in relapsed/refractory MM and Waldenström’s
Please login below to download this issue (PDF)